ASP Isotopes (NASDAQ:ASPI) CFO Heather Kiessling Sells 80,000 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 80,000 shares of the business’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total value of $464,000.00. Following the transaction, the chief financial officer owned 732,500 shares in the company, valued at approximately $4,248,500. This trade represents a 9.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

ASP Isotopes Trading Down 0.9%

ASP Isotopes stock opened at $5.71 on Tuesday. The stock has a 50-day moving average of $7.31 and a two-hundred day moving average of $8.51. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. ASP Isotopes Inc. has a one year low of $3.65 and a one year high of $14.49. The stock has a market cap of $632.90 million, a PE ratio of -4.39 and a beta of 3.42.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). The business had revenue of $4.89 million for the quarter, compared to analysts’ expectations of $2.25 million. ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%. On average, research analysts anticipate that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Hedge Funds Weigh In On ASP Isotopes

Institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in ASP Isotopes by 37.9% during the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock worth $43,451,000 after acquiring an additional 1,241,024 shares during the period. AWM Investment Company Inc. boosted its position in ASP Isotopes by 6.2% in the 1st quarter. AWM Investment Company Inc. now owns 4,511,186 shares of the company’s stock worth $21,157,000 after purchasing an additional 265,000 shares in the last quarter. Philadelphia Financial Management of San Francisco LLC increased its holdings in shares of ASP Isotopes by 11.2% during the 1st quarter. Philadelphia Financial Management of San Francisco LLC now owns 3,508,062 shares of the company’s stock valued at $16,453,000 after purchasing an additional 354,517 shares in the last quarter. Rovida Investment Management Ltd increased its holdings in shares of ASP Isotopes by 45.5% during the 3rd quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company’s stock valued at $30,688,000 after purchasing an additional 1,000,000 shares in the last quarter. Finally, Rovida Advisors Inc. acquired a new position in shares of ASP Isotopes in the 2nd quarter valued at $16,148,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on ASPI shares. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, December 22nd. Cantor Fitzgerald began coverage on ASP Isotopes in a research note on Thursday, December 4th. They set an “overweight” rating and a $13.00 price target on the stock. Loop Capital set a $15.00 price objective on ASP Isotopes in a report on Monday, October 27th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 target price on shares of ASP Isotopes in a report on Monday, November 24th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.